Carcinomas
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix (NCT05063916) | M.D. Anderson Cancer Center | 2022-02-28 |
| School Response to Families Who Have Children With Cancer (NCT01148082) | Stanford University | 2010-09-01 |
| Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35) (NCT01026415) | Seagen Inc. | 2009-12-01 |
| B-Receptor Signaling in Cardiomyopathy (NCT01135849) | Daniel Bernstein | 2008-11-01 |
| Symptom Assessment With Patient Surveys (NCT01135823) | Stanford University | 2006-07-01 |
| Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment (NCT00935675) | Gustave Roussy, Cancer Campus, Grand Paris |
Track Carcinomas automatically
Every clearance here is in the API, with alerts when new ones post.